Basic Information
| LncRNA/CircRNA Name | LINC-ROR |
| Synonyms | LINC-ROR, ROR, lincRNA-RoR |
| Region | GRCh38_18:57054558-57072119 |
| Ensemble | ENSG00000258609 |
| Refseq | NR_048536 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR, Western blot |
| Sample | Prostate tumor tissues,cell lines(PC-3, DU-145, 22RV1,Lncap) |
| Expression Pattern | up-regulated |
| Function Description | QRT-PCR results demonstrated that ROR levels in PCa tissues were notably higher than that in normal ones, and the difference was statistically significant. |
| Pubmed ID | 30915739 |
| Year | 2019 |
| Title | Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt. |
External Links
| Links for LINC-ROR | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |